High frequency of valganciclovir underdosing for cytomegalovirus prophylaxis after renal transplantation

Abstract

Most patients do not receive the recommended valganciclovir dose. Despite obvious underdosing in a large proportion of patients, effective prophylaxis was maintained and it was not associated as a risk factor for CMV viraemia or leucopenia.